Focus Partners Wealth
DNA icon

Focus Partners Wealth’s Ginkgo Bioworks DNA Stock Holding History

Focus Partners Wealth’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.6K Buy
11,842
+814
+7% +$6.77K ﹤0.01% 2551
2025
Q4 		$123K Buy
+11,028
New +$119K ﹤0.01% 2527

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Focus Partners Wealth's DNA Position: Q1 2026 in Review

Focus Partners Wealth increased its Ginkgo Bioworks (DNA) stake by 7.4% in Q1 2026, buying an estimated $6.77K and bringing the position to 11,842 shares worth $72.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2551.

Focus Partners Wealth first reported a position in DNA in Q4 2025 and has held it in 2 quarters since. The position peaked at $123K in Q4 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Focus Partners Wealth held 11,842 shares of Ginkgo Bioworks worth $72.6K as of Q1 2026.
  • Focus Partners Wealth bought 814 Ginkgo Bioworks shares in Q1 2026, an estimated $6.77K.
  • Ginkgo Bioworks made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2551 holding.
  • Focus Partners Wealth first reported a position in Ginkgo Bioworks in Q4 2025 and has held it in 2 quarters since.
  • Focus Partners Wealth's Ginkgo Bioworks position peaked at $123K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.